Apoptosis in CADASIL: An in vitro study of lymphocytes and fibroblasts from a cohort of Italian patients

Journal of Cellular Physiology

Volumn 219, Issue 2, 2009, Pages 494-502

  Formichi, Patrizia ^a   Radi, Elena ^a   Battisti, Carla ^a   Di Maio, Giuseppe ^a   Tarquini, Ermelinda ^a   Leonini, Alessandra ^a   Di Stefano, Anna ^a   Dotti, Maria Teresa ^a   Federico, Antonio ^a,b  

^a UNIVERSITY OF SIENA   (Italy)

^b UO Malattie Neurometaboliche   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 DEOXYRIBOSE; CASPASE 3; LIPOCORTIN 5; NOTCH3 RECEPTOR; PHOSPHATIDYLSERINE; CASPASE; DEOXYRIBOSE;

ADULT; AGAR GEL ELECTROPHORESIS; AGED; APOPTOSIS; ARTICLE; CADASIL; CELL MEMBRANE DEPOLARIZATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; FIBROBLAST; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE MUTATION; HUMAN; HUMAN CELL; ITALY; MALE; MITOCHONDRIAL MEMBRANE; NICK END LABELING; OXIDATIVE STRESS; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; CELL CULTURE; CYTOLOGY; GENETICS; LYMPHOCYTE; METABOLISM; MIDDLE AGED; MITOCHONDRIAL MEMBRANE POTENTIAL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; AGED; APOPTOSIS; CADASIL; CASPASES; CELLS, CULTURED; DEOXYRIBOSE; ENZYME ACTIVATION; FEMALE; FIBROBLASTS; HUMANS; IN SITU NICK-END LABELING; ITALY; LYMPHOCYTES; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MIDDLE AGED; PHOSPHATIDYLSERINES;

EID: 62149096107     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21695     Document Type: Article

References (40)

1. Artavanis-Tsakonas S, Rand MD, Lake RJ. 1999. Notch signaling: Cell fate control and signal integration in development. Science 284:770-776.
2. Barbieri D, Troiano L, Grassilli E, Agnesini C, Cristofalo EA, Monti D, Capri M, Cossarizza A, Franceschi C. 1992. Inhibition of apoptosis by a zinc: A reappraisal. Biochem Biophys Res Commun 187:1256-1261.
3. Battisti C, Formichi P, Tripodi SA, Mangiavacchi P, Tosi P, Federico A. 1996. Increased apoptotic response to 2-deoxy-D-ribose in ataxia-telagiectasia. J Neurol Sci 144:128-134.
4. Baudrimont M, Dubas F, Joutel A, Tournier-Lasserve E, Bousser MG. 1993. Autosomal dominant leukoencephalopaty and subcortical ischemic stroke. A clinicopathological study. Stroke 24:122-125.
5. Boyum A. 1984. Separation of lymphocytes, granulocytes, and monocytes from human blood using iodinated density gradient media. Methods Enzymol 108:88-102.
6. Campos AH, Wang W, Pollman MJ, Gibbons GH. 2002. Determinants of Notch-3 receptor expression and signaling in vascular smooth muscle cells: Implications in cell-cycle regulation. Circ Res 91:999-1006.
7. Chabriat H, Tournier-Lasserve E, Vahedi K, Leys D, Joutel A, Nibbio A, Escaillas JP, Iba-Zizen MT, Bracard S, Tehindrazanarivelo A. 1995. Autosomal dominant migraine with MRI white-matter abnormalities mapping to the CADASIL locus. Neurology 45:1086-1091.
8. de la Peña P, Bornstein B, del Hoyo P, Fernández-Moreno MA, Martín MA, Campos Y, Gómez-Escalonilla C, Molina JA, Cabello A, Arenas J, Garesse R. 2001. Mitochondrial dysfunction associated with a mutation in the Notch3 gene in a CADASIL family. Neurology 57:1235-1238.
9. Dotti MT, De Stefano N, Bianchi S, Malandrini A, Battisti C, Cardaioli E, Federico A. 2004. A novel NOTCH3 frameshift deletion and mitochondrial abnormalities in a patient with CADASIL. Arch Neurol 61:942-945.
10. Duru NK, Morshedi MS, Schuffner A, Oehninger S. 2001. Cryopreservation-thawing of fractionated human spermatozoa is associated with membrane phosphatidylserine externalization and not DNA fragmentation. J Androl 22:646-651.
11. Eastman A. 1995. Assays for DNA fragmentation, endonucleases, and intracellular pH and Ca2+ associated with apoptosis. Methods Cell Biol 46:41-55.
12. Ekert PG, Silke J, Vaux DL. 1999. Caspase inhibitors. Cell Death Differ 6:1081-1086.
13. Finnilä S, Tuisku S, Herva R, Majamaa K. 2001. A novel mitochondrial DNA mutation and a mutation in the Notch3 gene in a patient with myopathy and CADASIL. J Mol Med 79:641-647.
14. Formichi P, Battisti C, Tripodi SA, Tosi P, Federico A. 2000. Apoptotic response and cell cycle transition in ataxia telangiectasia cells exposed to oxidative stress. Life Sci 66:1893-1903.
15. Formichi P, Radi E, Battisti C, Tarquini E, Leonini A, Di Stefano A, Federico A. 2006. Human fibroblasts undergo oxidative stress-induced apoptosis without internucleosomal DNA fragmentation. J Cell Physiol 208:289-297.
16. Gavrieli Y, Sherman Y, Ben-Sasson SA. 1992. Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J Cell Biol 119:493-501.
17. Gibbons GH, Pollman MJ. 2000. Death receptors, intimal disease, and gene therapy: Are therapies that modify cell fate moving too Fas? Circ Res 86:1009-1012.
18. Haruki N, Kawaguchi KS, Eichenberg S, Massion PP, Gonzalez A, Gazdar AF, Minna JD, Carbone DP, Dang TP. 2005. Dominant negative Notch3 receptor inhibits mitogen-activaetd protein kinase pathway and the growth of human lung cancer. Cancer Res 65:3555-3561.
19. Ihalainen S, Soliymani R, Iivanainen E, Mykkänen K, Sainio A, Pöyhönen M, Elenius K, Järveläinen H, Viitanen M, Kalimo H, Baumann M. 2007. Proteome analysis of cultivated vascular smooth muscle cells from a CADASIL patient. Mol Med 13:305-314.
20. Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, Alamowitch S, Domenga V, Cécillion M, Marechal E, Maciazek J, Vayssiere C, Cruaud C, Cabanis EA, Ruchoux MM, Weissenbach J, Bach JF, Bousser MG, Tournier-Lasserve E. 1996. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383:707-710.
21. Joutel A, Andreux F, Gaulis S, Domenga V, Cecillon M, Battail N, Piga N, Chapon F, Godfrain C, Tournier-Lasserve E. 2000. The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J Clin Invest 105:597-605.
22. Kalimo H, Ruchoux MM, Viitanen M, Kalaria RJ. 2002. CADASIL: A common form of hereditary arteriopathy causing brain infarcts and dementia. Brain Pathol 12:371-384.
23. Kaneto H, Fujii J, Myint T, Miyazawa N, Islam KN, Kawasaki Y, Suzuki K, Nakamura M, Tatsumi H, Yamasaki Y. Taniguchi N. 1996. Reducing sugars trigger oxidative modification and apoptosis in pancreatic β-cells by provoking oxidative stress through the glycation reaction. Biochem J 320:855-863.
24. Kletsas D, Barbieri D, Stahakos D, Botti B, Bergamini S, Tomasi A, Monti D, Malorni W, Franceschi C. 1998. The highly reducing sugar 2-deoxy-D-ribose induces apoptosis in human fibroblasts by reduced glutathione depletion and cytoskeletal disruption. Biochem Biophys Res Comm 243:416-425.
25. Lieven CJ, Vrabec JP, Levin LA. 2003. The effects of oxidative stress on mitochondrial transmembrane potential in retinal ganglion cells. Antioxid Redox Signal 5:641-646.
26. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. 1991. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271-279.
27. Peters N, Holtmannspotter N, Opherk C, Gschwendtner A, Herzog J, Samann P, Dichgans M. 2006. Brain volume changes in CADASIL: A serial MRI study in pure subcortical ischaemic vascular disease. Neurology 66:1517-1522.
28. Ruchoux MM, Maurage CA. 1997. CADASIL: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. J Neuropathol Exp Neurol 56:947-964.
29. Ruchoux MM, Chabriat H, Bousser MG, Baudrimont T, Tournier-Lasserve E. 1994. Presence of ultrastructural arterial lesions in muscle and skin vessels of patients with CADASIL. Stroke 25:2291-2292.
30. Ruchoux MM, Guerouaou D, Vandenhaute B, Pruvo JP, Vermesh P, Leys D. 1995. Systemic vascular smooth cells impairement in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Acta Neuropathol 89:500-512.
31. Ruchoux MM, Brulin P, Leteurtre E, Maurage CA. 2000. Skin biopsy value and leukoaraiosis. Ann NY Acad Sci 903:285-292.
32. Rufa A, Malandrini A, Dotti MT, Berti G, Salvadori C, Federico A. 2005 Typical pathological changes of CADASIL in the optic nerve. Neurol Sci 26:271-274.
33. Schröder JM, Sellhaus B, Jörg J. 1995. Identification of the characteristic vascular changes in a sural nerve biopsy of a case with cerebral autosomal arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Acta Neuropathol (Berl) 89:116-121.
34. Telford WG, King LE, Fraker PJ. 1991. Evaluation of glucocorticoid- induced DNA fragmentation in mouse thymocytes by flow cytometry. Cell Prolif 24:447-459.
35. Tournier-Lasserve E, Joutel A, Melki J, Weissenbach J, Lathrop GM, Chabriat H, Mas JL, Cabanis EA, Baudrimont M, Maciazek J, Bach MA, Bousser MG. 1993. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nat Genet 3:256-259.
36. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. 1995. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 184:39-51.
37. Viswanathan A, Gray F, Bousser MG, Baudrimont M, Chabriat H. 2006. Cortical neuronal apoptosis in CADASIL. Stroke 37:2690-2695.
38. Wang W, Prince CZ, Mou Y, Pollman MJ. 2002. Notch3 signaling in vascular smooth muscle cells induces c-FLIP expression via ERK/MAPK activation. Resistance to Fas ligand-induced apoptosis. J Biol Chem 277:21723-21729.
39. Wang W, Prince CZ, Hu X, Pollman MJ. 2003. HRT1 modulates vascular smooth muscle cell proliferation and apoptosis. Biochem Biophys Res Comm 308:596-601.
40. Wang T, Baron M, Trump D. 2008. An overview of Notch3 function in vascular smooth muscle cells. Prog Biophys Mol Biol 96:499-509.